Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies

Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy

(2018) H. K. Olberg et al.   EUROPEAN JOURNAL OF NEUROLOGY

Age and immunity: What is “immunosenescence”?

(2018) Graham Pawelec   EXPERIMENTAL GERONTOLOGY

Vaccines and multiple sclerosis: a systematic review

(2016) Mia Topsøe Mailand et al.   JOURNAL OF NEUROLOGY

Atypical inflammatory demyelinating syndromes of the CNS

(2016) Todd A Hardy et al.   LANCET NEUROLOGY

Disease-modifying therapies and infectious risks in multiple sclerosis

(2016) Alexander Winkelmann et al.   Nature Reviews Neurology

Disease modifying therapies for relapsing multiple sclerosis

(2016) Dean M Wingerchuk et al.   BMJ-British Medical Journal

Disease modifying therapies for relapsing multiple sclerosis

(2016) Dean M Wingerchuk et al.   BMJ-British Medical Journal

Role of the innate and adaptive immune responses in the course of multiple sclerosis

(2015) Bernhard Hemmer et al.   LANCET NEUROLOGY

Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis

(2015) L. Kappos et al.   NEUROLOGY

Sex-based Biology and the Rational Design of Influenza Vaccination Strategies

(2014) S. L. Klein et al.   JOURNAL OF INFECTIOUS DISEASES

Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study

(2014) Henning K Olberg et al.   Multiple Sclerosis Journal

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies

(2014) Paolo Pellegrino et al.   VACCINE

Hospital admission due to infections in multiple sclerosis patients

(2013) S. Montgomery et al.   EUROPEAN JOURNAL OF NEUROLOGY

Pathology and disease mechanisms in different stages of multiple sclerosis

(2013) Hans Lassmann   JOURNAL OF THE NEUROLOGICAL SCIENCES

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

(2013) A. Bar-Or et al.   NEUROLOGY

Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy

(2013) Matthias Mehling et al.   PLoS One

Vaccination against infection in patients with multiple sclerosis

(2012) Micha Loebermann et al.   Nature Reviews Neurology

Humoral immune response to influenza vaccine in natalizumab-treated MS patients

(2012) Mattias Vågberg et al.   NEUROLOGICAL RESEARCH

H1N1 and Seasonal Influenza Vaccine Safety in the Vaccine Safety Datalink Project

(2011) Grace M. Lee et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Immune-mediated CNS diseases: A review on nosological classification and clinical features

(2011) Uwe K. Zettl et al.   AUTOIMMUNITY REVIEWS

Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination

(2011) Nuala McNicholas et al.   JOURNAL OF NEUROLOGY

Immunizations and risk of multiple sclerosis: systematic review and meta-analysis

(2011) Mauricio F. Farez et al.   JOURNAL OF NEUROLOGY

Seasonal and H1N1v influenza vaccines in MS: Safety and compliance

(2011) Eitan Auriel et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study

(2011) Mauricio F Farez et al.   Multiple Sclerosis Journal

Antibody Response After a Single Dose of an AS03-Adjuvanted Split-Virion Influenza A (H1N1) Vaccine in Heart Transplant Recipients

(2011) Sven Meyer et al.   TRANSPLANTATION

Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination

(2011) S. Elizabeth Williams et al.   VACCINE

The changing demographic pattern of multiple sclerosis epidemiology

(2010) Nils Koch-Henriksen et al.   LANCET NEUROLOGY

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study

(2010) M. Loebermann et al.   VACCINE

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET